BOUNDLESS BIO, INC. Operating Lease, Payments
BOUNDLESS BIO, INC. (BOLD) reported Operating Lease, Payments of $13.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-07
- BOUNDLESS BIO, INC. operating lease, payments for the quarter ending 2026-06-30 was $11.70M.
- BOUNDLESS BIO, INC. operating lease, payments for the quarter ending 2026-03-31 was $1.70M, a 1600.00% increase year-over-year.
- BOUNDLESS BIO, INC. operating lease, payments for the quarter ending 2025-12-31 was $1.80M, a 260.00% increase year-over-year.
- BOUNDLESS BIO, INC. operating lease, payments for the quarter ending 2025-09-30 was $700.00K, a 0.00% change year-over-year.
- BOUNDLESS BIO, INC. operating lease, payments for fiscal 2025 was $2.60M, a 0.00% change from fiscal 2024.
- BOUNDLESS BIO, INC. operating lease, payments for fiscal 2024 was $2.60M, a 7.14% decline from fiscal 2023.
- BOUNDLESS BIO, INC. operating lease, payments for fiscal 2023 was $2.80M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $11.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $13.40M 10-Q · filed 2026-08-07 | $15.20M derived: sum of 3 quarters · filed 2026-08-07 | $15.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.70M 10-Q · filed 2026-05-08 | $3.50M derived: sum of 2 quarters · filed 2026-05-08 | $4.20M derived: sum of 3 quarters · filed 2026-05-08 | $4.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.50M derived: sum of 2 quarters · filed 2026-03-09 | $2.50M derived: sum of 3 quarters · filed 2026-08-07 | $2.60M 10-K · filed 2026-03-09 |
| 2025-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $700.00K derived: sum of 2 quarters · filed 2026-08-07 | $800.00K 10-Q · filed 2025-11-05 | $1.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $100.00K 10-Q · filed 2026-08-07 | $600.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-08 | $600.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.30M derived: sum of 3 quarters · filed 2026-05-08 | $2.00M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $1.20M derived: sum of 2 quarters · filed 2026-03-09 | $1.90M derived: sum of 3 quarters · filed 2026-03-09 | $2.60M 10-K · filed 2026-03-09 |
| 2024-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.40M derived: sum of 2 quarters · filed 2025-11-05 | $2.10M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.40M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $700.00K 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | $2.80M 10-K · filed 2025-03-27 | |||
| 2023-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.40M 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $700.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |